This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 28/1/112    most recent ATVBAHA.107.153304v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lee, H.-Y. Articles by Kim, H.-S. Search for Related Content PubMed PubMed Citation Articles by Lee, H.-Y. Articles by Kim, H.-S.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:112.)
© 2008 American Heart Association, Inc.

Cell Biology/Signaling

FOXO3a Turns the Tumor Necrosis Factor Receptor Signaling Towards Apoptosis Through Reciprocal Regulation of c-Jun N-Terminal Kinase and NF-B

Hae-Young Lee; Seock-Won Youn; Ju-Young Kim; Kyung-Woo Park; Chang-Il Hwang; Woong-Yang Park; Byung-Hee Oh; Young-Bae Park; Kenneth Walsh; Jeong-Sun Seo; Hyo-Soo Kim

From the Innovative Research Institute for Cell Therapy (H.-Y.L., S.-W.Y., J.-Y.K., K.-W.P., Y.-B.P., H.-S.K.), Seoul National University Hospital, the Department of Internal Medicine (H.-Y.L., S.-W.Y., K.-W.P., B.-H.O., Y.-B.P., H.-S.K.) and the Department of Biochemistry and Molecular Biology (C.-I.H., W.-Y.P., J.-S.S.), Seoul National University College of Medicine, Seoul, Korea; and the Whitaker Cardiovascular Institute (K.W.), Boston University School of Medicine, Boston, Mass.

Correspondence to Hyo-Soo Kim, MD, Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong Chongno-gu Seoul 110-744 Korea. E-mail hyosoo{at}snu.ac.kr

Abstract

Objective— We evaluated the full range effects of FOXO3a in endothelial cells (ECs) by microarray analysis and investigated the role of FOXO3a regulating TNF receptor signaling pathway.

Methods and Results— Human umbilical vein endothelial cells (HUVECs) were transfected with adenoviral vectors expressing constitutively active FOXO3a (Ad-TM-FOXO3a). Ad-TM-FOXO3a transfection caused remarkable apoptosis, which were accompanied with upregulation of genes related with TNF receptor signaling, such as TNF-, TANK (TRAF-associated NF-B activator), and TTRAP (TRAF and TNF receptor-associated protein). Furthermore, B-Ras1 (IB-interacting Ras-like protein-1) which is known to block IB degradation was found increased, and intranuclear translocation of NF-B was inhibited. GADD45β and XIAP, negative regulators of c-Jun N-terminal kinase (JNK), were suppressed and JNK activity was increased. Attenuation of TNF signaling pathway either by blocking antibody for TNF receptor or by blocking JNK with DMAP (6-dimethylaminopurine) or Ad-TAM67 (dominant negative c-Jun) cotransfection, significantly reduced FOXO3a-induced apoptosis. Finally, treatment of vasculature with heat shock, an activator of endogenous FOXO3a, resulted in EC apoptosis, which was completely rescued by Ad-TAM67.

Conclusion— FOXO3a promotes apoptosis of ECs, through activation of JNK and suppression of NF-B. These data identify a novel role of FOXO3a to turn TNF receptor signaling to a proapoptotic JNK-dependent pathway.

The effects of FOXO3a on endothelial cells were evaluated by microarray analysis. The activation of FOXO3a promotes apoptosis through activation of JNK and suppression of NF-B. This study identifies a novel role of FOXO3a in directing TNF receptor signaling to a proapoptotic JNK-dependent pathway.

Key Words: FOXO3a • JNK • NF-B • apoptosis